ClinicalTrials.Veeva

Menu

Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging (DLRPRO)

C

Centre Hospitalier Universitaire, Amiens

Status

Completed

Conditions

Prostate Cancer

Treatments

Other: MR prostate exam

Study type

Interventional

Funder types

Other

Identifiers

NCT06094322
PI2022_843_0108

Details and patient eligibility

About

MR prostate exam is essential for the diagnosis, workup and follow-up of prostate cancer. It allows to detect subclinical prostate cancer following an increase in the level of PSA. The investigators can score the lesion according to the PIRADS classification and obtain an estimate of lesion malignancy. To perform this classification, T2 and DWI sequences are essential.

Detection and characterization of malignant lesion is important to address appropriate patient care pathway. The purpose of this project is to evaluate novel deep learning (DL) T2-weighted TSE (T2DL) and Diffusion (DWIDL) sequences for prostate MR exam and investigate its impact on diagnostic, examination time, image quality, and PI-RADS classification compared to standard T2-weighted TSE (T2S) and standard Diffusion (DWIS) sequences.

Enrollment

3 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 ans
  • Healthy subject without history of hepatic disease
  • Patient addressed for an prostate MRI
  • Ability to give consent

Exclusion criteria

  • claustrophobia,
  • major obesity (>140 kg),
  • Patient under guardianship or curators
  • Age < 18 years,
  • Women,
  • History of prostatectomy or irradiation of the prostate
  • any contraindication to MRI exam

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Aurélien DELABIE, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems